Novonesis Statistics

Total Valuation

Novonesis has a market cap or net worth of EUR 25.21 billion. The enterprise value is 26.94 billion.

Market Cap	25.21B
Enterprise Value	26.94B

Important Dates

The next estimated earnings date is Wednesday, February 26, 2025.

Earnings Date	Feb 26, 2025
Ex-Dividend Date	Aug 30, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.26%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	345.19M

Valuation Ratios

The trailing PE ratio is 89.14.

PE Ratio	89.14
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	34.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 34.47, with an EV/FCF ratio of 42.66.

EV / Earnings	95.26
EV / Sales	8.85
EV / EBITDA	34.47
EV / EBIT	51.67
EV / FCF	42.66

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.18.

Current Ratio	1.11
Quick Ratio	0.67
Debt / Equity	0.18
Debt / EBITDA	2.53
Debt / FCF	3.15
Interest Coverage	11.54

Financial Efficiency

Return on equity (ROE) is 4.38% and return on invested capital (ROIC) is 4.12%.

Return on Equity (ROE)	4.38%
Return on Assets (ROA)	3.45%
Return on Capital (ROIC)	4.12%
Revenue Per Employee	291,303
Profits Per Employee	27,056
Employee Count	6,756
Asset Turnover	0.32
Inventory Turnover	2.66

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+11.67%
50-Day Moving Average	56.85
200-Day Moving Average	57.33
Relative Strength Index (RSI)	40.15
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novonesis had revenue of EUR 3.04 billion and earned 282.79 million in profits. Earnings per share was 1.02.

Revenue	3.04B
Gross Profit	1.42B
Operating Income	525.05M
Pretax Income	367.36M
Net Income	282.79M
EBITDA	667.26M
EBIT	525.05M
Earnings Per Share (EPS)	1.02

Full Income Statement

Balance Sheet

The company has 260.80 million in cash and 1.99 billion in debt, giving a net cash position of -1.73 billion.

Cash & Cash Equivalents	260.80M
Total Debt	1.99B
Net Cash	-1.73B
Net Cash Per Share	n/a
Equity (Book Value)	11.01B
Book Value Per Share	39.60
Working Capital	177.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 890.95 million and capital expenditures -259.41 million, giving a free cash flow of 631.54 million.

Operating Cash Flow	890.95M
Capital Expenditures	-259.41M
Free Cash Flow	631.54M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 46.66%, with operating and profit margins of 17.24% and 9.29%.

Gross Margin	46.66%
Operating Margin	17.24%
Pretax Margin	12.07%
Profit Margin	9.29%
EBITDA Margin	21.92%
EBIT Margin	17.24%
FCF Margin	20.74%

Dividends & Yields

Novonesis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-60.83%
Years of Dividend Growth	4
Payout Ratio	99.19%
Buyback Yield	0.26%
Shareholder Yield	0.26%
Earnings Yield	1.87%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novonesis has an Altman Z-Score of 3.78.

Altman Z-Score	3.78
Piotroski F-Score	n/a